Lv21
120 积分 2024-11-01 加入
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
7小时前
待确认
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
1天前
已完结
Deucravacitinib in moderate‐to‐severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO‐1 and PSO‐2)
12天前
已完结
The pipeline and market for psoriasis drugs
12天前
已完结
银屑病治疗药物临床试验设计的科学考虑
13天前
已完结
Deucravacitinib: The First FDA-Approved Oral TYK2 Inhibitor for Moderate to Severe Plaque Psoriasis
13天前
已完结
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
3个月前
已完结
[Recommendations for the diagnosis and treatment of Sjögren's syndrome in China]
3个月前
已完结
皖公网安备34019202002308
